Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed
about
Immunoglobulin G avidity in diagnosis of toxoplasmic lymphadenopathy and ocular toxoplasmosisDevelopment of fully automated determination of marker-specific immunoglobulin G (IgG) avidity based on the avidity competition assay format: application for Abbott Architect cytomegalovirus and Toxo IgG Avidity assaysA new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluidSerological diagnosis of Epstein-Barr virus infection: Problems and solutionsImmunoglobulin G avidity in differentiation between early and late antibody responses to West Nile virusUse of immunoglobulin G antibody avidity for differentiation of primary human herpesvirus 6 and 7 infections.Analysis of mumps vaccine failure by means of avidity testing for mumps virus-specific immunoglobulin G.Increases in the levels of Coxiella burnetii-specific immunoglobulin G1 and G3 antibodies in acute Q fever and chronic Q fever.Antibody avidity in swine lymphocyte antigen-defined miniature pigs.Use of an anti-hepatitis C virus (HCV) IgG avidity assay to identify recent HCV infection.Humoral immune response to primary rubella virus infection.Role of cytomegalovirus (CMV) IgG avidity testing in diagnosing primary CMV infection during pregnancy.Use of immunoglobulin g avidity to determine the course of disease in visceral and post-kala-azar dermal leishmaniasis patients.Immunoglobulin G avidity testing in serum and cerebrospinal fluid for analysis of measles virus infection.Evaluation of commercial rubella immunoglobulin G avidity assays.An indirect enzyme-linked immunosorbent assay for the identification of antibodies to Senecavirus A in swineRubella-specific IgG subclass avidity ELISA and its role in the differentiation between primary rubella and rubella reinfection.Differentiation of primary from nonprimary genital herpes infections by a herpes simplex virus-specific immunoglobulin G avidity assay.Passive hemagglutination test for measles immunity and serodiagnosis.Measurement of rotavirus-neutralizing coproantibody in children by fluorescent focus reduction assay.Diagnostic potential of baculovirus-expressed rubella virus envelope proteins.Potential role of IgG avidity for diagnosing toxoplasmosisUse of an immunoglobulin G avidity test to discriminate between primary and secondary dengue virus infections.Human Parvoviruses.Neutralization efficiency is greatly enhanced by bivalent binding of an antibody to epitopes in the V4 region and the membrane-proximal external region within one trimer of human immunodeficiency virus type 1 glycoproteins.Detection of immunoglobulin M (IgM), IgA, and IgG Norwalk virus-specific antibodies by indirect enzyme-linked immunosorbent assay with baculovirus-expressed Norwalk virus capsid antigen in adult volunteers challenged with Norwalk virus.Immunoglobulin G antibody avidity in patients with respiratory syncytial virus infection.Primary humoral antibody response to Coxiella burnetii, the causative agent of Q fever.Single-serum diagnosis of rubella by combined use of the hemagglutination inhibition and passive hemagglutination tests.ABO, D blood typing and subtyping using plug-based microfluidics.
P2860
Q24548871-D2DD4A53-A6D4-4E75-8241-A373C50DC58CQ24645130-26C16AF7-D238-46F8-89EF-B7CC4FFE47AFQ24799955-43D7ECC0-2F35-4055-9D9C-5AD9EA734466Q26829346-47310748-B87D-42D5-A983-0EC39D9ED28BQ27472834-11D179B4-1C75-4AA3-8460-4C5ED2C45B5DQ33971533-66E2F446-EFDB-488A-A066-B2EC88DB333CQ33999591-CF624B12-E9AB-4F11-88DD-844A5287AC26Q33999603-A8B0FEFC-E71F-43D0-A8CB-C0DEC7FD34F6Q34094441-E0AFF1AA-F543-4493-A03F-D9B01E55096FQ34120470-848D25FC-3FC8-428D-83E2-EF1E3C0B8964Q34429454-0C4F466C-A6A6-4122-A1EE-0DC118AD0931Q34701351-9053A945-2DD1-45FB-ABD1-DB861537A552Q34975018-1C94C9CD-51AF-49CE-8EA9-F7FBD98B3099Q35226116-CC7A9CE8-94AA-4C58-B3ED-3E6F0D1F919CQ35690274-18579911-9438-40B1-AF21-334546070B26Q36281713-3DFD5B17-A6FB-4410-9711-210FB654D810Q36473117-396BCACF-3B38-4EA0-8F07-015F4FD87AC2Q36545092-D87E3702-417F-47AC-BF7D-7B9BF6FFFE67Q37146720-AF8E35F7-BEC7-4A28-A6FF-FD1F678BBC5EQ37186785-4D9CEB00-113F-4A56-981D-46ADFB088873Q37242385-79065FEC-584B-47AC-B0E2-2BDCB25AF18BQ37269641-EDBF3E99-91B8-4E88-8787-B02AA1EE5AD0Q38967313-58D0F983-C3F6-4C60-B885-5B3CE295C22AQ38996997-228C7A50-0671-4B8D-900B-CABB50EA68D7Q39704592-84FE0EB2-18E3-487B-977A-D0A208279DAEQ40181308-A15B23D9-EA79-43CE-9670-D654EB8A2E66Q40186524-BD920528-67C1-4F75-96E5-D452C4A94438Q40187080-986962B8-8B43-4CD7-9BAA-B9DBB810EEFDQ40205340-AF63DED3-6A03-4707-848B-94103D3D6EE6Q41407564-2EB3C931-8F49-4A9A-AE25-856CB9043D99
P2860
Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agent is employed
description
1984 nî lūn-bûn
@nan
1984 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1984 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1984年の論文
@ja
1984年論文
@yue
1984年論文
@zh-hant
1984年論文
@zh-hk
1984年論文
@zh-mo
1984年論文
@zh-tw
1984年论文
@wuu
name
Changes in antibody avidity af ...... n-denaturing agent is employed
@ast
Changes in antibody avidity af ...... n-denaturing agent is employed
@en
Changes in antibody avidity af ...... n-denaturing agent is employed
@nl
type
label
Changes in antibody avidity af ...... n-denaturing agent is employed
@ast
Changes in antibody avidity af ...... n-denaturing agent is employed
@en
Changes in antibody avidity af ...... n-denaturing agent is employed
@nl
prefLabel
Changes in antibody avidity af ...... n-denaturing agent is employed
@ast
Changes in antibody avidity af ...... n-denaturing agent is employed
@en
Changes in antibody avidity af ...... n-denaturing agent is employed
@nl
P2093
P2860
P1476
Changes in antibody avidity af ...... n-denaturing agent is employed
@en
P2093
P2860
P304
P407
P577
1984-09-01T00:00:00Z